Morfin Alkaloid-Int (Morphine Hydrochloride Trihydrate)

Morphine Hydrochloride Trihydrate, the active ingredient in Morfin Alkaloid-Int, is an opioid analgesic presented as an injectable solution for intramuscular, intravenous, subcutaneous use. It provides analgesia for moderate to severe pain in adult patients.

GNH USA supplies Morfin Alkaloid-Int as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Morphine is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for: - Moderate to severe acute pain: provides rapid analgesia for trauma or injury. - Postoperative pain: reduces pain following surgical procedures. - Cancer pain: manages chronic severe pain associated with malignant disease.

Morphine may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea - Vomiting - Constipation - Drowsiness - Dizziness - Sweating

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Coma - Anaphylactic reaction - Dependence or addiction - Adrenal insufficiency

Morphine requires careful clinical assessment and monitoring. - Pain assessment: confirm severity before initiating therapy. - Respiratory function: evaluate baseline breathing and avoid use in patients with compromised ventilation. - Organ impairment: adjust use in renal or hepatic dysfunction. - Concomitant CNS depressants: avoid or use with caution when combined with benzodiazepines or alcohol. - Dependence risk: monitor for signs of tolerance, dependence, or misuse. - Store at controlled room temperature: keep in original container, protect from light and moisture.

Morphine interacts with several drug classes that may alter its safety profile.

Major Interactions (Avoid): - Other central nervous system depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression. - Monoamine oxidase inhibitors (MAOIs): increase risk of serotonin syndrome and severe hypotension. - Potent CYP3A4 inhibitors (e.g., ketoconazole): can raise morphine plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect. - Diuretics: may enhance hypotensive response. - Antihistamines and anticholinergics: can increase sedation and anticholinergic side effects.